Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
about
Risk determination and prevention of breast cancerA Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.Two decades after BRCA: setting paradigms in personalized cancer care and preventionThe latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markersExome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerVariants of estrogen-related genes and breast cancer risk in European and African American women.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkGenome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.Breast Cancer Update 2014 - Focus on the Patient and the Tumour.Altered Gene Expression Associated with microRNA Binding Site PolymorphismsGenetic predisposition to ductal carcinoma in situ of the breastFine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer contextGWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patientsIdentification of four novel susceptibility loci for oestrogen receptor negative breast cancerThe MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancerGenomic Biomarkers for Breast Cancer Risk.Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes.Replication of Early B-cell Factor 1 (EBF1) Gene-by-psychosocial Stress Interaction Effects on Central Adiposity in a Korean Population.MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.Trans-ethnic follow-up of breast cancer GWAS hits using the preferential linkage disequilibrium approach.The associations between MDM4 gene polymorphisms and cancer riskAn unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.Previous GWAS hits in relation to young-onset breast cancer.Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population.Breast cancer risk prediction using a clinical risk model and polygenic risk score.Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.The most important questions in cancer research and clinical oncology : Question 1. Could the vertical transmission of human papilloma virus (HPV) infection account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal carciCommon genetic variation drives molecular heterogeneity in human iPSCs.Analysis of Tumor Biology to Advance Cancer Health Disparity Research.Update Breast Cancer 2017 - Implementation of Novel Therapies.Rethinking ovarian cancer genomics: where genome-wide association studies stand?Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.Common Genetic Variation and Breast Cancer Risk - Past, present, and future.
P2860
Q26991921-B48072D6-53DD-4594-A0A7-3473645E4FD9Q28384141-C0B60BBB-0A7E-4B2B-9ABB-7ADC6825C83CQ33565679-35E0160E-F22B-44DC-83B9-011B65E58884Q33820594-F58C8CEC-956A-4851-9A39-94D325025F6BQ34258373-10835A95-A0E5-4EC2-9E0B-F3333B2E7556Q34408752-B3E17464-AB11-4E64-8F8A-F787B4EBDA16Q34426481-CD9453C8-C839-4EAF-B758-1D7B70914381Q34521706-C3F4363B-7F34-4E1D-86C5-D0756C8085B0Q35054455-21E46467-5F82-4639-A66B-BF5A25083883Q35061252-E03479FF-157E-450D-965D-87804A961F25Q35074030-CAAE1051-FD0D-49F5-AA87-7DAB89B702E2Q35180940-19B57431-C8A6-4159-A7C7-25CF1C8473B1Q35819085-5E454F21-09A4-4A5B-9E75-63E67A0F14CFQ35925620-DD1AFE48-99A8-46FA-AEF5-7E13169B3656Q36111237-61393576-9884-43C7-9ED2-4AD1B183EC7FQ36146953-2183DB07-4EFD-42CB-871E-B66D545A38C0Q36169701-8EA86B28-79ED-4DB2-937F-F6F98154ACFAQ36859142-084A665F-CB66-4E27-AD5B-00622FDE5823Q37208141-7E5FCB8B-93B9-4BC9-91BB-95C5B74792D6Q37242239-168FDE63-5A79-4590-A52B-E16C8A53B236Q37271961-7D2FF7B6-26F5-4137-9B14-F10211F55857Q37343394-A8AE615F-FDF0-41BD-A122-AC152BE393D3Q37441522-2BD62DBF-4B78-4D52-858E-672DEBD352CDQ37644934-BCC1800C-DA5B-43B3-BB3B-463D9F06A951Q37686157-320F818D-F515-4E3F-A22B-E27EC62D5958Q37688285-B7FDE3E8-F6DB-409D-845E-18805A901A4BQ38647794-F0506FBF-3643-404B-BD50-14F1ACDC34A6Q38794059-482B1120-6EFA-40E7-96B3-3BDB3C147CCCQ39647103-C8C92350-AF66-4913-99AB-E5584392B0D4Q40474074-8604B7CE-5CAC-4172-AFA2-4B2EF92E4A4DQ40591033-906A73F2-A4D7-4466-ACAD-7CCC0A1AC927Q40605693-31156E10-6109-4A74-986D-D6AC1F17CF8AQ41011976-5F3D9DD7-1E1D-474B-8947-B24A2E73000DQ42330145-110BB251-763A-456B-AEAE-FF885A2FD6ECQ42830893-D6EDB0D1-D531-4117-8728-4C68C6CE269CQ46324231-D3C18DB5-B8A6-4A85-9E59-F8F5ED505E89Q47110841-9C68D8D6-3AE8-426B-9B75-C43E4EA04C9BQ47592913-77E0CDB6-C875-4EF2-B195-791FEC80E1A0Q47663995-C0E53965-EEFB-4FAA-B04D-FB107CFF8233Q47703662-18FC52C1-CE75-4307-BB10-E9F6F177D497
P2860
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genome-wide association study ...... triple-negative breast cancer.
@ast
Genome-wide association study ...... triple-negative breast cancer.
@en
type
label
Genome-wide association study ...... triple-negative breast cancer.
@ast
Genome-wide association study ...... triple-negative breast cancer.
@en
prefLabel
Genome-wide association study ...... triple-negative breast cancer.
@ast
Genome-wide association study ...... triple-negative breast cancer.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Genome-wide association study ...... triple-negative breast cancer.
@en
P2093
Andrew K Godwin
Arndt Hartmann
Athanassios Vratimos
Brigitte Rack
Charles L Shapiro
Christoph Scholz
Curtis Olswold
Daniel W Visscher
Diana Torres
Dimitrios Pectasides
P2860
P304
P3181
P356
10.1093/CARCIN/BGT404
P407
P50
P5008
P577
2013-12-09T00:00:00Z